The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling

Tingting Zhu; Linqiang Zhang; Chengbin Li; Xiaoqiong Tan; Jing Liu; Huiqin Li; Qijing Fan; Zhiguo Zhang; Mingfeng Zhan; Lin Fu; Jinbo Luo; Jiawei Geng; Yingjie Wu; Xiaoju Zou; Bin Liang

doi:10.1016/j.jgg.2022.02.013

Volume 49 Issue 4

Apr. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2022 > 49(4): 338-349

PDF( 4065 KB)

The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling

doi: 10.1016/j.jgg.2022.02.013

a Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China;
b Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan 650204, China;
c Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China;
d School of Traditional Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, China;
e Infectious Diseases Department and Hepatic Diseases Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, China;
f Infectious Diseases Department and Hepatic Diseases Department, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650034, China;
g School of Laboratory Animal & Shandong Laboratory Animal Center, Science and Technology Innovation Center,Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250021, China;
h Institute for Genome Engineered Animal Models of Human Diseases, National Center of Genetically Engineered Animal Models for International Research, Liaoning Provence Key Lab of Genome Engineered Animal Models Dalian Medical University, Dalian, Liaoning 116044, China

Funds:

This work was supported by the National Natural Science Foundation of China (U1702288, 81700520, U1702287, 31671230, 91857113, 31860323, 32000818), the Yunnan Applied Basic Research Projects (2019FY003021, 2017FA007, 2018FB117, 202101AT070009), the Ministry of Science and Technology of the People's Republic of China (2018YFA0800700), the Yunnan Province Innovation Team of Intestinal Microecology-Related Disease Research and Technological Transformation (202005AE160010).

Received Date: 2021-12-25
Accepted Date: 2022-02-22
Rev Recd Date: 2022-02-22
Publish Date: 2022-04-30

Abstract

Abstract

Liver fibrosis is a key transformation stage and also a reversible pathological process in various types of chronic liver diseases. However, the pathogenesis of liver fibrosis still remains elusive. Here, we report that the calcium binding protein A11 (S100A11) is consistently upregulated in the integrated data from GSE liver fibrosis and tree shrew liver proteomics. S100A11 is also experimentally activated in liver fibrosis in mouse, rat, tree shrew, and human with liver fibrosis. While overexpression of S100A11 in vivo and in vitro exacerbates liver fibrosis, the inhibition of S100A11 improves liver fibrosis. Mechanistically, S100A11 activates hepatic stellate cells (HSCs) and the fibrogenesis process via the regulation of the deacetylation of Smad3 in the TGF-β signaling pathway. S100A11 physically interacts with SIRT6, a deacetylase of Smad2/3, which may competitively inhibit the interaction between SIRT6 and Smad2/3. The subsequent release and activation of Smad2/3 promote the activation of HSCs and fibrogenesis. Additionally, a significant elevation of S100A11 in serum is observed in clinical patients. Our study uncovers S100A11 as a novel profibrogenic factor in liver fibrosis, which may represent both a potential biomarker and a promising therapy target for treating liver fibrosis and fibrosis-related liver diseases.
- Chronic liver diseases,
- Liver fibrosis,
- S100A11,
- TGF-β,
- SIRT6,
- Smad3

FullText(HTML)

References(49)

References

Allen, B.G., Walsh, M.P., Durussel, I., Cox, J.A., 1996. Characterization of the Ca²⁺-binding properties of calgizzarin (S100C) isolated from chicken gizzard smooth muscle. Biochem. Cell. Biol. 74, 687-694

Andres Cerezo, L., Hulejova, H., Sumova, B., Kropackova, T., Krystufkova, O., Klein, M., Mann, H.F., Zamecnik, J., Pecha, O., Pavelka, K., et al., 2019. Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis. Cytokine 116, 13-20

Arrese, M., Hernandez, A., Astete, L., Estrada, L., Cabello-Verrugio, C., Daniel, C., 2018. TGF-β and hepatocellular carcinoma: when a friend becomes an enemy. Curr. Protein Pept. Sci. 19, 1172–1179

Arthur, M.J., 2002. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 122, 1525-1528

Bataller, R., Brenner, D.A., 2001. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21, 437-451

Bataller, R., Brenner, D.A., 2005. Liver fibrosis. J. Clin. Invest. 115, 209-218

Bedossa, P., Peltier, E., Terris, B., Franco, D., Poynard, T., 1995. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21, 760-766

Caballeria, L., Pera, G., Arteaga, I., Rodriguez, L., Aluma, A., Morillas, R.M., de la Ossa, N., Diaz, A., Exposito, C., Miranda, D., et al., 2018. High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study. Clin. Gastroenterol. Hepatol. 16, 1138-1145.e5

Cecil, D.L., Johnson, K., Rediske, J., Lotz, M., Schmidt, A.M., Terkeltaub, R., 2005. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J. Immunol. 175, 8296-8302

Chalasani, N., Abdelmalek, M.F., Garcia-Tsao, G., Vuppalanchi, R., Traber, P.G., 2019. Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension. Gastroenterology 158, 1334-1345.e5

Cui, A., Ding, D., Li, Y., 2021. Regulation of hepatic metabolism and cell growth by the ATF/CREB family of transcription factors. Diabetes 70, 653-664

Donato, R., 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668

Donghee, K., Li, A.A., Chiranjeevi, G., Ali, K.M., George, C., Glenn, J.S., Aijaz, A., 2018. Changing trends in etiology-based annual mortality from chronic liver disease, From 2007 Through 2016. Gastroenterology 155, 1154-1163.e3

Fransvea, E., Angelotti, U.F., Antonaci, S., Giannelli, G., 2008. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology 47, 1557-1566

Friedman, S.L., 2003. Liver fibrosis--from bench to bedside. J. Hepatol. 38, S38-S53

Gong, X.M., Li, Y.F., Luo, J., Wang, J.Q., Wei, J., Wang, J.Q., Xiao, T., Xie, C., Hong, J., Ning, G., et al., 2019. Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance. Nat. Metab. 1, 570-583

Gorrell, M.D., 2007. Liver fibrosis: the hepatocyte revisited. Hepatology 46, 1659-1661

Gressner, A.M., Weiskirchen, R., 2006. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J. Cell Mol. Med. 10, 76-99

Hernandezgea, V., Friedman, S.L., 2011. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 6, 425-456

Inoue, Y., Itoh, Y., Abe, K., Okamoto, T., Daitoku, H., Fukamizu, A., Onozaki, K., Hayashi, H., 2007. Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene 26, 500-508

Jessica, E.S., Shay, James, P. Hamilton, 2018. Hepatic fibrosis: avenues of investigation and clinical implications. Clin. Liver Dis. 11, 111-114

Laia, C., Francesco, D., Serena, M., Daniel, C.D., Aristidis, M., Gianluigi, G., Isabel, F., 2018. TGF-β and the tissue microenvironment: relevance in fibrosis and cancer. Int. J. Mol. Sci. 19, 1294

Lanaya, H., Natarajan, A., Komposch, K., Li, L., Amberg, N., Chen, L., Wculek, S.K., Hammer, M., Zenz, R., Peck-Radosavljevic, M., et al., 2014. EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation. Nat. Cell Biol. 16, 972-977

Larter, C.Z., Yeh, M.M., 2008. Animal models of NASH: getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 23, 1635-1648

Li, J., Qu, X., Ricardo, S.D., Bertram, J.F., Nikolic-Paterson, D.J., 2010. Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am. J. Pathol. 177, 1065-1071

Lim, Y.S., Kim, W.R., 2008. The global impact of hepatic fibrosis and end-stage liver disease. Clin. Liver Dis. 12, 733-746, vii

Luo, X., Xie, H., Long, X., Zhou, M., Xu, Z., Shi, B., Jiang, H., Li, Z., 2013. EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression. PLoS One 8, e83332

Maity, S., Muhamed, J., Sarikhani, M., Kumar, S., Ahamed, F., Spurthi, K.M., Ravi, V., Jain, A., Khan, D., Arathi, B.P., et al., 2020. Sirtuin 6 deficiency transcriptionally up-regulates TGF-β signaling and induces fibrosis in mice. J. Biol. Chem. 295, 415-434

Martinez-Martinez, E., Ibarrola, J., Lachen-Montes, M., Fernandez-Celis, A., Jaisser, F., Santamaria, E., Fernandez-Irigoyen, J., Lopez-Andres, N., 2017. Differential proteomics reveals S100-A11 as a key factor in aldosterone-induced collagen expression in human cardiac fibroblasts. J. Proteonomics. 166, 93-100

Oh, H.Y., Shin, S.K., Heo, H.S., Ahn, J.S., Kwon, E.Y., Park, J.H., Cho, Y.Y., Park, H.J., Lee, M.K., Kim, E.J., et al., 2013. Time-dependent network analysis reveals molecular targets underlying the development of diet-induced obesity and non-alcoholic steatohepatitis. Genes Nutr. 8, 301-316

Popov, Y., Schuppan, D., 2009. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50, 1294-1306

Safronova, A., Araujo, A., Camanzo, E., Moon, T.J., Elliott, M.R., Beiting, D.P., Yarovinsky, F., 2019. Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii. Nat. Immunol. 20, 64-72

Saho, S., Satoh, H., Kondo, E., Inoue, Y., Yamauchi, A., Murata, H., Kinoshita, R., Yamamoto, K., Futami, J., Putranto, E.W., et al., 2016. Active secretion of dimerized S100A11 induced by the peroxisome in mesothelioma cells. Cancer Microenviron. 9, 93-105

Sakaguchi, M., Sonegawa, H., Murata, H., Kitazoe, M., Futami, J., Kataoka, K., Yamada, H., Huh, N., 2008. S100A11, an dual mediator for growth regulation of human keratinocytes. Mol. Biol. Cell 19, 78-85

Senturk, S., Mumcuoglu, M., Gursoyyuzugullu, O., Cingoz, B., Akcali, K.C., Ozturk, M., 2010. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 52, 966-974

Shang, X., Cheng, H., Zhou, R., 2008. Chromosomal mapping, differential origin and evolution of theS100gene family. Genet. Sel. Evol. 40, 449

Simonsson, M., Kanduri, M., Gronroos, E., Heldin, C.H., Ericsson, J., 2006. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J. Biol. Chem. 281, 39870-39880

Sobolewski, C., Abegg, D., Berthou, F., Dolicka, D., Calo, N., Sempoux, C., Fournier, M., Maeder, C., Ay, A.S., Clavien, P.A., et al., 2020. S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut 69, 1841-1854

Teng, F., Jiang, J., Zhang, J., Yuan, Y., Li, K., Zhou, B., Zhou, X., Liu, W., Zhang, P., Liu, D., et al., 2021. The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling. Metabolism 117, 154725

Teratani, T., Tomita, K., Furuhashi, H., Sugihara, N., Higashiyama, M., Nishikawa, M., Irie, R., Takajo, T., Wada, A., Horiuchi, K., et al., 2019. Lipoprotein lipase up-regulation in hepatic stellate cells exacerbates liver fibrosis in nonalcoholic steatohepatitis in mice. Hepatol. Commun. 3, 1098-1112

Xu, M., Xu, H.H., Lin, Y., Sun, X., Wang, L.J., Fang, Z.P., Su, X.H., Liang, X.J., Hu, Y., Liu, Z.M., et al., 2019. LECT2, a ligand for Tie1, plays a crucial role in liver fibrogenesis. Cell 178, 1478-1492.e20

Yang, M., Wang, C., Li, S., Xv, X., She, S., Ran, X., Li, S., Hu, H., Hu, P., Zhang, D., et al., 2017. Annexin A2 promotes liver fibrosis by mediating von Willebrand factor secretion. Dig. Liver Dis. 49, 780-788

Yanguas, S.C., Cogliati, B., Willebrords, J., Maes, M., Colle, I., van den Bossche, B., de Oliveira, C., Andraus, W., Alves, V.A.F., Leclercq, I., et al., 2016. Experimental models of liver fibrosis. Arch. Toxicol. 90, 1025-1048

Zhang, J., Li, Y., Liu, Q., Huang, Y., Li, R., Wu, T., Zhang, Z., Zhou, J., Huang, H., Tang, Q., et al., 2021a. Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells. Hepatology 73, 1140-1157

Zhang, L., Zhang, Z., Li, Y., Liao, S., Wu, X., Chang, Q., Liang, B., 2015. Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease. Sci. Rep. 5, 15970

Zhang, L., Zhu, T., Miao, H., Liang, B., 2021b. The calcium binding protein S100A11 and its roles in diseases. Front. Cell Dev. Biol. 9, 693262

Zhang, L., Zhang, Z.G., Li, C.B., Zhu, T.T., Gao, J., Zhou, H., Zheng, Y.Z., Chang, Q., Wang, M.S., Wu, J.Y., et al., 2021c. S100A11 promotes liver steatosis via FOXO1-mediated autophagy and lipogenesis. Cell Mol. Gastroenterol. Hepatol. 11, 697-724

Zhao, Y., Shi, X., Ding, C., Feng, D., Li, Y., Hu, Y., Wang, L., Gao, D., Tian, X., Yao, J., 2018. Carnosic acid prevents COL1A2 transcription through the reduction of Smad3 acetylation via the AMPKα1/SIRT1 pathway. Toxicol. Appl. Pharmacol. 339, 172-180

Zhong, X., Huang, M., Kim, H.G., Zhang, Y., Chowdhury, K., Cai, W., Saxena, R., Schwabe, R.F., Liangpunsakul, S., Dong, X.C., 2020. SIRT6 protects against liver fibrosis by deacetylation and suppression of SMAD3 in hepatic stellate cells. Cell Mol. Gastroenterol. Hepatol. 10, 341-364

Relative Articles

Supplements(0)

Cited By

Proportional views